Table 1.
PHC center | Months recruiting | Attendees | FINDRISC | Screening reach | At risk of T2D | OGTT performed | Refusal rate | Non- diabetic | Included in study |
---|---|---|---|---|---|---|---|---|---|
n Total | n Total | n (%) | n | n (%) | n | ||||
Intervention centers | |||||||||
SV | 24.5 | 4097 | 256 | 6.2 % | 158 (61.7 %) | 114 | 27.8 % | 100 (87.7 %) | 77 |
GK | 25.7 | 7440 | 282 | 3.8 % | 212 (75.2 %) | 116 | 44.3 % | 98 (84.5 %) | 82 |
BL | 20.8 | 2068 | 296 | 14.3 % | 116 (39.2 %) | 52 | 55.2 % | 47 (90.4 %) | 39 |
LG | 18.6 | 1951 | 391 | 20.0 % | 125 (32.0 %) | 57 | 54.4 % | 52 (91.2 %) | 51 |
DB | 28.2 | 6229 | 125 | 2.0 % | 100 (80.0 %) | 59 | 41.0 % | 56 (94.9 %) | 54 |
IZ | 26.1 | 5106 | 456 | 8.9 % | 260 (57.0 %) | 162 | 37.7 % | 143 (88.3 %) | 123 |
AR | 17.6 | 3081 | 371 | 12.0 % | 81 (21.8 %) | 33 | 59.2 % | 32 (96.7 %) | 28 |
Total | 29,972 | 2177 | 7.3 % | 1052 (48.4 %) | 593 | 43.3 % | 528 (88.4 %) | 454 | |
Control centers | |||||||||
ZU | 28.6 | 4632 | 310 | 6.7 % | 219 (70.6 %) | 176 | 19.6 % | 146 (83.0 %) | 146 |
LL | 25.4 | 5041 | 256 | 5.1 % | 150 (58.6 %) | 106 | 28.7 % | 93 (87.7 %) | 93 |
TX | 19.4 | 3928 | 509 | 13.0 % | 165 (32.4 %) | 82 | 43.0 % | 78 (95.1 %) | 78 |
AZ | 25.8 | 3370 | 325 | 9.6 % | 205 (63.1 %) | 163 | 19.0 % | 143 (87.7 %) | 143 |
IR | 14.9 | 6227 | 128 | 2.1 % | 79 (61.7 %) | 41 | 45.6 % | 35 (85.4 %) | 35 |
AB | 22.7 | 5589 | 183 | 3.3 % | 138 (75.4 %) | 100 | 26.8 % | 90 (90.0 %) | 90 |
SM | 26.3 | 8534 | 282 | 3.3 % | 120 (42.6 %) | 53 | 54.2 % | 49 (92.4 %) | 49 |
Total | 37,321 | 1993 | 5.3 % | 1076 (54.0 %) | 721 | 33.0 % | 634 (88.3 %) | 634 |
T2D type-2 diabetes, FINDRISC Finnish Diabetes Risk Score, OGTT oral glucose tolerance test, PHC primary health care